🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 21 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/02/2023 | 121,32 | 124,80 | 120,51 | 124,57 | +2,06% | 3,54% | 823.300 |
| 16/02/2023 | 123,64 | 125,96 | 121,42 | 122,05 | -2,14% | 3,67% | 1.018.000 |
| 15/02/2023 | 120,97 | 125,44 | 119,79 | 124,72 | +3,62% | 4,67% | 1.159.700 |
| 14/02/2023 | 120,16 | 123,49 | 119,51 | 120,36 | +0,13% | 3,31% | 835.100 |
| 13/02/2023 | 120,67 | 120,95 | 119,69 | 120,20 | -0,21% | 1,04% | 656.900 |
| 10/02/2023 | 120,43 | 121,60 | 119,43 | 120,45 | -0,56% | 1,80% | 624.300 |
| 09/02/2023 | 122,32 | 123,09 | 120,89 | 121,13 | -0,19% | 1,80% | 937.900 |
| 08/02/2023 | 121,29 | 121,91 | 119,64 | 121,36 | +0,47% | 1,87% | 1.126.400 |
| 07/02/2023 | 117,90 | 120,98 | 116,25 | 120,79 | +2,50% | 4,01% | 1.120.500 |
| 06/02/2023 | 119,05 | 121,11 | 117,67 | 117,84 | -0,97% | 2,89% | 782.000 |
| 03/02/2023 | 120,21 | 121,05 | 118,85 | 119,00 | -1,04% | 1,83% | 777.200 |
| 02/02/2023 | 122,86 | 122,86 | 118,74 | 120,25 | -1,72% | 3,35% | 1.080.400 |
| 01/02/2023 | 125,00 | 125,48 | 119,70 | 122,36 | -2,09% | 4,62% | 720.600 |
| 31/01/2023 | 120,64 | 125,56 | 120,64 | 124,97 | +3,40% | 4,08% | 841.200 |
| 30/01/2023 | 122,69 | 123,00 | 120,72 | 120,86 | -1,65% | 1,86% | 601.400 |
| 27/01/2023 | 124,53 | 126,11 | 121,89 | 122,89 | -1,27% | 3,39% | 724.400 |
| 26/01/2023 | 123,59 | 125,33 | 122,30 | 124,47 | +1,06% | 2,45% | 945.000 |
| 25/01/2023 | 127,57 | 128,40 | 122,55 | 123,16 | -4,06% | 4,59% | 1.457.300 |
| 24/01/2023 | 128,95 | 133,47 | 127,83 | 128,37 | +0,03% | 4,37% | 1.779.700 |
| 23/01/2023 | 129,65 | 129,91 | 128,01 | 128,33 | -1,45% | 1,47% | 671.700 |
| 20/01/2023 | 128,40 | 130,79 | 127,05 | 130,22 | +1,89% | 2,91% | 734.600 |
| 19/01/2023 | 128,72 | 129,18 | 127,46 | 127,80 | -0,74% | 1,34% | 558.500 |
| 18/01/2023 | 130,37 | 131,95 | 126,97 | 128,75 | -0,96% | 3,82% | 736.300 |
| 17/01/2023 | 125,78 | 131,85 | 125,78 | 130,00 | +2,60% | 4,83% | 1.800.300 |
| 13/01/2023 | 121,47 | 130,68 | 121,35 | 126,70 | +4,19% | 7,68% | 1.426.900 |
| 12/01/2023 | 120,00 | 122,64 | 118,10 | 121,60 | +1,22% | 3,78% | 848.600 |
| 11/01/2023 | 120,00 | 122,41 | 118,78 | 120,13 | +0,84% | 3,03% | 908.100 |
| 10/01/2023 | 118,93 | 121,99 | 118,73 | 119,13 | +1,36% | 2,74% | 1.030.600 |
| 09/01/2023 | 122,96 | 122,97 | 116,10 | 117,53 | -3,88% | 5,59% | 1.330.600 |
| 06/01/2023 | 122,10 | 122,97 | 120,15 | 122,27 | +0,54% | 2,31% | 743.700 |